09-05-2025 22:51 via medpagetoday.com

Novel IL-7 Receptor Antagonist Shows Promise in Ulcerative Colitis

(MedPage Today) -- SAN DIEGO--Patients with moderate to severe ulcerative colitis experienced clinical, endoscopic, histological, and biological improvements with the first-in-class interleukin (IL)-7 receptor antagonist lusvertikimab compared...
Read more »

Medical Industry news



Study: Rheumatology Patients Prefer In-Person Visits
Want to Get Rid of Faulty Race-Based Dx and Treatment Criteria? It Can Be Done.
Mystery Brain Disease in New Brunswick May Not Have Been a Mystery After All
FDA OKs First At-Home Test for Cervical Cancer Screening
Biomarker-Informed IBD Therapy Guidance Improved Disease Control
FDA Will Allow Three Color Additives Made From Minerals, Algae, and Flower Petals
Efruxifermin Did Not Reduce Fibrosis in MASH-Related Compensated Cirrhosis
Roflumilast Foam Eases Scalp and Body Psoriasis
Measles Cases Top 1,000: A Crisis of Complacency
Warnings on Budget, Drug Prices; Surveillance for Prostate Cancer; AI Cancer Wins
Exploring the Expanding Role of Surgery in Metastatic Prostate Cancer
MedPod Today: Makary Interview; DEI Order Targets Medical Education; HICPAC Ends
Ventricular Arrhythmias More Likely to Strike Users of Meth, Cocaine
Severe Cases of Virus Tied to Polio-like Paralysis Often Occurs in Healthy Kids
Desktop versie